Who Just RaisedWoburn, MA · Health Care · Form D filed Aug 28, 2026
Aegle Therapeutics Corp raised $2.3M
Aegle Therapeutics Corp is a biotechnology company based in Woburn, Massachusetts. In a Form D filed with the SEC on August 28, 2026, it reported raising $2,277,698 from 17 investors as part of an offering of up to $2,277,698. The first sale in the offering took place on August 4, 2026.
Aegle Therapeutics is a pioneer in regenerative medicine developing extracellular vesicle (EV) therapy to meaningfully improve the lives of those
- 3rd Form D since 2020. Earlier new notices: Mar 3, 2026 · Jan 7, 2020. All filings on EDGAR
$9.2M raised since 2020
3 Form D offerings, as reported to the SEC, the first in Jan 7, 2020. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 28, 2026 | $2.3M | $2.3M | 17 |
| Mar 3, 2026 | $456K | $700K | 10 |
| Jan 7, 2020 | $6.5M | $6.5M | 8 |
Lead score
20 out of 100
early raise budget to spend website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- aegletherapeutics.com
- Amount raised
- $2,277,698
- Offering size
- $2,277,698
- Investors so far
- 17
- First sale
- August 4, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Woburn, Massachusetts
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $2,277,698 | $2,277,698 | 17 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 24, 2026 · Health Care funding in Massachusetts · August 2026 funding report
Similar raises
Axelyf, Inc.
Chestnut Hill, MA · filed Oct 132nd Form D since 2025
Soterya, Inc.
Boston, MA · filed Oct 13First Form DStill raising
Bioventrix, Inc.
Mansfield, MA · filed Oct 8
OUR VISION: Extend Life Span and Improve Quality of Life for Heart Failure Patients OUR VISION Extending Life Span and Improving Quality of Life for Heart Failure Patients How Revivent Therapy May…
26th Form D since 2009Still raising
Revbio, Inc.
Lowell, MA · filed Oct 2
TETRANITE is a regenerative bone glue. Bioengineered for a body of applications, TETRANITE® promises to transform bone repair.
4th Form D since 2019
Opus KSD, Inc.
Pembroke, MA · filed Oct 13rd Form D since 2016
Xact Bio, Inc.
Boston, MA · filed Sep 28First Form DStill raising
Way Biosolutions, Inc.
Cambridge, MA · filed Sep 25First Form D
AutoIVF, Inc.
Natick, MA · filed Sep 254th Form D since 2020